BACKGROUND AND PURPOSE: Retinal vascular caliber changes have been shown to predict stroke, but the underlying mechanism of this association is unknown. We examined the relationship between retinal vascular caliber with brachial flow-mediated dilation (FMD), a measure of systemic endothelial function. METHODS: The Multi-Ethnic Study of Atherosclerosis (MESA) is a population-based study of persons 45 to 84 years of age residing in 6 US communities free of clinical cardiovascular disease at baseline. Brachial FMD data were collected at baseline (July 2000 to June 2002), and retinal vascular caliber was measured from digital retinal photographs at the second examination, immediately after the first (August 2002 to January 2004). Data were available for 2851 participants for analysis. RESULTS: The mean brachial FMD was 4.39+/-2.79%. After adjusting for age and gender, brachial FMD was reduced in persons with wider retinal venular caliber (changes in FMD -0.25, 95% CI, -0.36, - 0.13; P<0.001, per SD increase in venular caliber). This relationship persists after adjusting for systolic blood pressure, serum total cholesterol, use of lipid-lowering and antihypertensive medication, body mass index, current smoking status, and hemoglobinA(1C) (-0.18; 95% CI -0.30, - 0.06; P=0.004, per SD increase in venular caliber). Brachial FMD was not associated with retinal arteriolar caliber. CONCLUSIONS: Persons with wider retinal venules have reduced brachial FMD, independent of other vascular risk factors. This suggests that retinal venular caliber, previously shown to predict stroke, may be a marker of underlying systemic endothelial dysfunction.
BACKGROUND AND PURPOSE: Retinal vascular caliber changes have been shown to predict stroke, but the underlying mechanism of this association is unknown. We examined the relationship between retinal vascular caliber with brachial flow-mediated dilation (FMD), a measure of systemic endothelial function. METHODS: The Multi-Ethnic Study of Atherosclerosis (MESA) is a population-based study of persons 45 to 84 years of age residing in 6 US communities free of clinical cardiovascular disease at baseline. Brachial FMD data were collected at baseline (July 2000 to June 2002), and retinal vascular caliber was measured from digital retinal photographs at the second examination, immediately after the first (August 2002 to January 2004). Data were available for 2851 participants for analysis. RESULTS: The mean brachial FMD was 4.39+/-2.79%. After adjusting for age and gender, brachial FMD was reduced in persons with wider retinal venular caliber (changes in FMD -0.25, 95% CI, -0.36, - 0.13; P<0.001, per SD increase in venular caliber). This relationship persists after adjusting for systolic blood pressure, serum total cholesterol, use of lipid-lowering and antihypertensive medication, body mass index, current smoking status, and hemoglobinA(1C) (-0.18; 95% CI -0.30, - 0.06; P=0.004, per SD increase in venular caliber). Brachial FMD was not associated with retinal arteriolar caliber. CONCLUSIONS:Persons with wider retinal venules have reduced brachial FMD, independent of other vascular risk factors. This suggests that retinal venular caliber, previously shown to predict stroke, may be a marker of underlying systemic endothelial dysfunction.
Authors: Tien Yin Wong; Michael D Knudtson; Ronald Klein; Barbara E K Klein; Stacy M Meuer; Larry D Hubbard Journal: Ophthalmology Date: 2004-06 Impact factor: 12.079
Authors: D R Meeking; M H Cummings; S Thorne; A Donald; P Clarkson; J R Crook; G F Watts; K M Shaw Journal: Diabet Med Date: 1999-10 Impact factor: 4.359
Authors: R Klein; A R Sharrett; B E Klein; L E Chambless; L S Cooper; L D Hubbard; G Evans Journal: Arterioscler Thromb Vasc Biol Date: 2000-06 Impact factor: 8.311
Authors: Tien Yin Wong; Ronald Klein; A Richey Sharrett; Bruce B Duncan; David J Couper; Barbara E K Klein; Larry D Hubbard; F Javier Nieto Journal: Ann Intern Med Date: 2004-02-17 Impact factor: 25.391
Authors: R Kawasaki; J M Tielsch; J J Wang; T Y Wong; P Mitchell; Y Tano; M Tominaga; T Oizumi; M Daimon; T Kato; S Kawata; T Kayama; H Yamashita Journal: Br J Ophthalmol Date: 2007-10-26 Impact factor: 4.638
Authors: M Kamran Ikram; Frank Jan de Jong; Johannes R Vingerling; Jacqueline C M Witteman; Albert Hofman; Monique M B Breteler; Paulus T V M de Jong Journal: Invest Ophthalmol Vis Sci Date: 2004-07 Impact factor: 4.799
Authors: Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy Journal: Am J Epidemiol Date: 2002-11-01 Impact factor: 4.897
Authors: Christopher T Dibble; Daichi Shimbo; R Graham Barr; Emilia Bagiella; Harjit Chahal; Corey E Ventetuolo; David M Herrington; Joao A C Lima; David A Bluemke; Steven M Kawut Journal: Chest Date: 2012-12 Impact factor: 9.410
Authors: Luenda E Charles; Ja K Gu; Claudia C Ma; Lisa M Grady; Anna Mnatsakanova; Michael E Andrew; Desta Fekedulegn; John M Violanti; Ronald Klein Journal: J Occup Environ Med Date: 2017-10 Impact factor: 2.162
Authors: Luenda E Charles; Desta Fekedulegn; Paul Landsbergis; Cecil M Burchfiel; Sherry Baron; Joel D Kaufman; Karen Hinckley Stukovsky; Kaori Fujishiro; Capri G Foy; Michael E Andrew; Ana V Diez Roux Journal: J Occup Environ Med Date: 2014-11 Impact factor: 2.162
Authors: Madeline H Meier; Nathan A Gillespie; Narelle K Hansell; Alex W Hewitt; Ian B Hickie; Yi Lu; John McGrath; Stuart MacGregor; Sarah E Medland; Cong Sun; Tien Y Wong; Margaret J Wright; Gu Zhu; Nicholas G Martin; David A Mackey Journal: Schizophr Res Date: 2015-02-16 Impact factor: 4.939
Authors: Ke Yang; Si Yan Zhan; Yuan Bo Liang; Xinrong Duan; Fenghua Wang; Tien Yin Wong; Lan Ping Sun; Ning-Li Wang Journal: Graefes Arch Clin Exp Ophthalmol Date: 2011-10-05 Impact factor: 3.117